sever
acut
respiratori
syndrom
sar
recent
describ
emerg
infecti
diseas
respons
atyp
pneumonia
start
novemb
china
end
februari
cluster
patient
observ
hong
kong
mainli
relat
close
contact
healthcar
worker
march
initi
worldwid
alert
diseas
rapidli
spread
around
world
initi
metapneumoviru
isol
sever
patient
rapidli
new
coronaviru
sar
coronaviru
isol
fulfil
koch
postul
hematolog
manifest
sar
precis
describ
lymphopenia
lymphocyt
deplet
often
associ
diseas
activ
report
case
patient
sar
relatedacut
respiratori
distress
syndrom
ard
evolut
character
two
episod
ard
associ
specif
cytokin
product
pattern
patient
man
underli
diseas
hiv
neg
stay
hanoi
februari
march
work
hanoi
french
hospit
patient
left
hanoi
march
travel
pari
travel
develop
short
breath
admit
march
infecti
diseas
depart
tourco
franc
admiss
febril
present
tachycardia
patient
also
hypoxem
sao
high
respiratori
rate
rapidli
requir
oxygen
supplement
chest
radiographi
show
bilater
opacif
interstiti
alveolar
involv
initi
treatment
associ
ceftriaxon
ofloxacin
ribavirin
patient
remain
stabl
h
worsen
ventilatori
statu
transfer
icu
non
invas
ventil
start
h
final
patient
intub
sedat
march
laboratori
abnorm
show
pao
fio
ratio
elev
level
aspart
aminotransferas
ul
white
blood
cell
cellsmm
rtpcr
sar
coronaviru
found
posit
sever
tracheal
sampl
corticosteroid
start
march
prednisolon
mgkg
mgd
administ
patient
start
improv
increas
pao
fio
ratio
progress
enhanc
chest
radiographi
march
ribavirin
discontinu
decreas
pt
low
platelet
count
increas
aspart
aminotransferas
level
haemolyt
anemia
april
chest
radiographi
show
nosocomi
pneumonia
bilater
infiltr
pao
fio
decreas
white
blood
cell
count
increas
empir
chemotherapi
start
associ
imipenem
amikacin
vancomycin
next
day
patient
slowli
improv
organ
failur
ever
develop
besid
pulmonari
syndrom
lymphocyt
remain
period
count
april
increas
observ
ratio
increas
sedat
disrupt
april
corticosteroid
decreas
mgd
patient
extub
april
chest
radiograph
almost
normal
april
patient
rapidli
deterior
second
respiratori
distress
pao
fio
decreas
temperatur
rais
lymphocyt
measur
interleukin
il
plasma
increas
morn
prior
episod
increas
afterward
sampl
fig
cytokin
rapidli
decreas
plasma
level
return
back
indetect
prednisolon
increas
mgd
second
episod
patient
start
improv
steroid
slowli
decreas
third
ard
start
may
compar
cytokin
product
profil
earli
increas
clinic
worsen
fig
increas
sampl
obtain
day
follow
episod
lymphocyt
number
measur
patient
die
multipl
organ
failur
juli
acut
respiratori
distress
syndrom
ard
character
acut
epitheli
endotheli
injuri
lead
respiratori
failur
role
cytokin
alreadi
extens
studi
medic
literatur
particular
focu
balanc
pro
antiinflammatori
cytokin
previous
demonstr
ard
high
dose
corticosteroid
benefici
effect
studi
corticosteroid
decreas
twice
time
patient
present
new
ard
first
april
second
end
may
tracheal
sampl
still
posit
sar
coronaviru
april
stool
start
posit
april
therefor
rule
possibl
exacerb
sar
infect
relat
corticosteroid
taper
possibl
could
rebound
follow
corticosteroid
withdraw
fact
time
dose
reach
mgd
clinic
statu
worsen
seem
difficult
decid
whether
viru
decreas
steroid
respons
serum
cytokin
follow
interest
pattern
especi
produc
h
cell
well
cell
growth
differenti
factor
activ
blymphocyt
activ
tlymphocyt
promot
product
h
cell
ige
blymphocyt
enhanc
macrophag
antigen
process
present
activ
induc
cytokin
product
sepsi
cytokin
increas
time
diagnosi
correl
mortal
ard
li
et
al
show
increas
level
compar
control
studi
level
reach
alway
produc
prior
clinic
deterior
systemat
sampl
patient
day
measur
perform
april
show
increas
realiz
stabl
extu
cytokin
result
consist
literatur
level
increas
rapidli
ard
april
march
level
reach
valu
shown
associ
low
likelihood
surviv
data
even
case
report
seem
interest
report
two
main
element
corticosteroid
must
probabl
decreas
slowli
sar
studi
confirm
need
use
could
interest
marker
diseas
icu
